List was last updated on
.-
- Diagnosis, Management, and Surveillance for Patients with PALB2, CHEK2, and ATM Gene Mutations.
- Fencer MG, Krupa KA, Bleich GC, Grumet S, Eladoumikdachi FG, Kumar S, Kowzun MJ, Potdevin LB.
- Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00034-4. doi: 10.1016/j.clbc.2023.02.004. Epub ahead of print.
-
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic.
- Zimovjanova M, Bielcikova Z, Miskovicova M, Vocka M, Zimovjanova A, Marian Rybar M, Novotny J, Petruzelka L.
- Cancers (Basel). 2023 Feb 8;15(4):1072. doi: 10.3390/cancers15041072.
-
- Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.
- Nomura H, Abe A, Fusegi A, Yoshimitsu T, Misaka S, Murakami A, Matsumoto T, Tsumura S, Kanno M, Aoki Y, Netsu S, Omi M, Tanigawa T, Okamoto S, Omatsu K, Yunokawa M, Kanao H, Habano E, Arakawa H, Kaneko K, Ueki A, Haruyama Y, Inari H, Ueno T.
- Sci Rep. 2023 Jan 19;13(1):1018. doi: 10.1038/s41598-023-28304-w.
- PMID: 36658289
- PubMed abstract
-
- Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review.
- Wei X, Oxley S, Sideris M, Kalra A, Sun L, Yang L, Legood R, Manchanda R.
- Cancers (Basel). 2022 Dec 12;14(24):6117. doi: 10.3390/cancers14246117.
- Review
- Free Full Text
-
- Sociodemographic, Clinical, and Variation Outcomes for Breast Cancer and Breast Cancer-Related Mutations in a Ten-Year Cohort From Neiva, Huila, Colombia.
- Olaya J, Sanjuan J, Torres-Lopez D, Olaya L, Gutierrez-Vargas M, Olaya G, Olaya JD.
- Cureus. 2022 Dec 6;14(12):e32257. doi: 10.7759/cureus.32257.
- PMID: 36620844
- PubMed abstract
-
- Mastectomy with one-stage or two-stage reconstruction in breast cancer: analysis of early outcomes and patient's satisfaction.
- Angela G, Alessandro P, Alessia T, Michele M, Rossella E, Marco M, Michele T, Giuseppe Massimiliano L, Walter L, Elisabetta P, Paolo PF, Ilaria SL, Giuseppe G, Mario T.
- Updates Surg. 2022 Nov 19. doi: 10.1007/s13304-022-01416-0. Epub ahead of print.
- PMID: 36401760
- PubMed abstract
-
- Receipt of Bilateral Mastectomy Among Women With Hereditary Breast Cancer.
- Reid S, Roberson ML, Koehler K, Shah T, Weidner A, Whisenant JG, Pal T.
- JAMA Oncol. 2022 Nov 3. doi: 10.1001/jamaoncol.2022.5162. Epub ahead of print.
- PMID: 36326735
- PubMed abstract
- Source abstract
-
- Revision Rate of Direct-to-Implant Breast Reconstruction: Is it Truly a Single-Stage Reconstruction? A Single-Surgeon Experience.
- Adler N, Carmon E, Houri P.
- Aesthetic Plast Surg. 2022 Oct 28. doi: 10.1007/s00266-022-03136-7. Epub ahead of print.
- PMID: 36307562
- PubMed abstract
- Source abstract
-
- Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.
- Powell CB, Laurent C, Garcia C, Hoodfar E, Karlea A, Kobelka C, Lee J, Roh J, Kushi LH.
- Gynecol Oncol. 2022 Oct 8:S0090-8258(22)01857-1. doi: 10.1016/j.ygyno.2022.10.001. Epub ahead of print.
- PMID: 36220669
- PubMed abstract
- Source abstract
-
- Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
- Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD.
- Ann Surg Oncol. 2022 Oct;29(11):6660-6668. doi: 10.1245/s10434-022-11916-3. Epub 2022 May 26.
- PMID: 35616744
- PubMed abstract
- Source abstract
-
- Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.
- Makhnoon S, Chen M, Levin B, Ensinger M, Mattie KD, Grana G, Shete S, Arun BK, Peterson SK.
- Cancer. 2022 Oct;128(20):3709-3717. doi: 10.1002/cncr.34429. Epub 2022 Aug 23.
- PMID: 35996941
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes.
- Comeaux JG, Culver JO, Lee JE, Dondanville D, McArthur HL, Quinn E, Gorman N, Ricker C, Li M, Lerman C.
- Mol Genet Genomic Med. 2022 Oct;10(10):e2031. doi: 10.1002/mgg3.2031. Epub 2022 Aug 25.
- PMID: 36054727
- PubMed abstract
- Source abstract
-
- Eligibility, uptake and response to germline genetic testing in women with DCIS.
- Turza L, Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Front Oncol. 2022 Aug 26;12:918757. doi: 10.3389/fonc.2022.918757.
- PMID: 36091166
- PubMed abstract
-
- Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.
- Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B.
- Cancer. 2022 Aug 15;128(16):3090-3098. doi: 10.1002/cncr.34349. Epub 2022 Jun 9.
- PMID: 35679147
- PubMed abstract
- Source abstract
-
- What are the considerations in patient selection and timing of risk-reducing mastectomy?
- Pederson HJ, Kurian AW, Al Hilli Z.
- Cleve Clin J Med. 2022 Aug 1;89(8):442-444. doi: 10.3949/ccjm.89a.21114.
- PMID: 35914935
- PubMed abstract
-
- Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC.
- Ohsumi S, Nakamura S, Miyata H, Watanabe C, Den H, Arai M.
- Jpn J Clin Oncol. 2022 Jul 30:hyac120. doi: 10.1093/jjco/hyac120. Epub ahead of print.
- PMID: 35905458
- PubMed abstract
- Source abstract
-
- Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire.
- Herold N, Hellmich M, Lichtenheldt F, Ataseven B, Hillebrand V, Wappenschmidt B, Schmutzler RK, Rhiem K.
- Genes (Basel). 2022 Jul 28;13(8):1357. doi: 10.3390/genes13081357.
- PMID: 36011268
- PubMed abstract
- Source abstract
-
- The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.
- Forrest LE, Forbes Shepherd R, Tutty E, Pearce A, Campbell I, Devereux L, Trainer AH, James PA, Young MA.
- J Pers Med. 2022 Jul 7;12(7):1112. doi: 10.3390/jpm12071112.
- PMID: 35887609
- PubMed abstract
- Source abstract
-
- Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature.
- Carlsson L, Thain E, Gillies B, Metcalfe K.
- Hered Cancer Clin Pract. 2022 Jun 22;20(1):25. doi: 10.1186/s13053-022-00229-x.
- PMID: 35733200
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective.
- Molina-Zayas M, Garrido-Navas C, García-Puche JL, Barwell J, Pedrinaci S, Atienza MM, García-Linares S, de Haro-Muñoz T, Lorente JA, Serrano MJ, Poyatos-Andújar A.
- Mol Genet Genomics. 2022 May;297(3):859-871. doi: 10.1007/s00438-022-01891-5. Epub 2022 Apr 22.
- PMID: 35451682
- PubMed abstract
-
- Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review.
- Simões Corrêa Galendi J, Kautz-Freimuth S, Stock S, Müller D.
- Cancers (Basel). 2022 Mar 31;14(7):1786. doi: 10.3390/cancers14071786.
- PMID: 35406563
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers.
- Sandoval RL, Polidorio N, Leite ACR, Cartaxo M, Pisani JP, Quirino CV, Cezana L, Pereira NG, Pereira AAL, Rossi BM, Achatz MI.
- Front Oncol. 2022 Mar 16;12:836937. doi: 10.3389/fonc.2022.836937.
- PMID: 35371985
- PubMed abstract
-
- Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- Saul H, Gursul D, Cassidy S, Evans G.
- BMJ. 2022 Feb 15;376:o258. doi: 10.1136/bmj.o258.
- PMID: 35168943
- PubMed abstract
- Source abstract
Original research:
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- PMID: 33568438
- PubMed abstract
- Source abstract
-
- ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
- Mittal A, Pramanik R.
- Ann Surg Oncol. 2022 Feb;29(2):1433-1434. doi: 10.1245/s10434-021-10880-8. Epub 2021 Oct 15.
- PMID: 34654988
- PubMed abstract
-
- Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- Marcinkute R, Woodward ER, Gandhi A, Howell S, Crosbie EJ, Wissely J, Harvey J, Highton L, Murphy J, Holland C, Edmondson R, Clayton R, Barr L, Harkness EF, Howell A, Lalloo F, Evans DG.
- J Med Genet. 2022 Feb;59(2):133-140. doi: 10.1136/jmedgenet-2020-107356. Epub 2021 Feb 10.
- PMID: 33568438
- PubMed abstract
- Source abstract
Research news:
Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- PMID: 35168943
- PubMed abstract
- Source abstract
-
- Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk-reducing surgeries in BRCA mutation carriers.
- Vasigh M, Eslami B, Elahi A, Kaviani A, Shirkoohi R, Majidzadeh K, Nazarian N, Omranipour R.
- Mol Genet Genomic Med. 2022 Feb;10(2):e1867. doi: 10.1002/mgg3.1867. Epub 2022 Jan 12.
- PMID: 35023322
- PubMed abstract
- Source abstract
-
- Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status.
- Logue CA, Pugh J, Foden P, Mahmood RD, Morgan RD, Mitchell C, Hasan J, Clamp AR, Jayson GC.
- Sex Med. 2022 Feb;10(1):100465. doi: 10.1016/j.esxm.2021.100465. Epub 2021 Dec 15.
- PMID: 34922303
- PubMed abstract
-
- Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li-Fraumeni syndrome.
- Siegel A, Bremer RC, Klein WMP, Savage SA, Loud JT, Khincha PP.
- Breast Cancer Res Treat. 2022 Jan;191(1):159-167. doi: 10.1007/s10549-021-06410-5. Epub 2021 Oct 15.
- PMID: 34652547
- PubMed abstract
- Source abstract
-
- Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system.
- Vargason AB, Turner CE, Shriver CD, Ellsworth RE.
- Genet Med. 2022 Jan;24(1):232-237. doi: 10.1016/j.gim.2021.08.002. Epub 2021 Nov 30.
- PMID: 34906450
- PubMed abstract
Podcast: January 2022: Providing access to quality healthcare for Non-Hispanic Black women reduces mortality. (Genetics in Medicine. GenePod)
-
- Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.
- John CS, Fong A, Alban R, Gillen J, Moore KM, Walsh CS, Li AJ, Rimel BJ, Amersi F, Cass I.
- Gynecol Oncol. 2022 Jan;164(1):202-207. doi: 10.1016/j.ygyno.2021.10.077. Epub 2021 Nov 30.
- PMID: 34862065
- PubMed abstract
- Source abstract
-
- Is there an increasing trend of risk-reducing prophylactic mastectomy procedure in preventing breast cancer among women?
- Arslan B, Tazeoglu D, Dag A, Berkesoglu M, Özdemir AA.
- Turk J Surg. 2021 Dec 31;37(4):347-354. doi: 10.47717/turkjsurg.2021.4963.
- PMID: 35677477
- PubMed abstract
- Source abstract
-
- Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer.
- Evans DG, Gandhi A, Wisely J, Clancy T, Woodward ER, Harvey J, Highton L, Murphy J, Barr L, Howell SJ, Lalloo F, Harkness EF, Howell A.
- Breast. 2021 Dec;60:45-52. doi: 10.1016/j.breast.2021.08.015. Epub 2021 Aug 26.
- PMID: 34464846
- PubMed abstract
-
- Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
- Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R.
- Ann Surg Oncol. 2021 Oct 2:1–10. doi: 10.1245/s10434-021-10870-w. Epub ahead of print.
- PMID: 34601666
- PubMed abstract
-
- Surgical Management of Hereditary Breast Cancer.
- Berger ER, Golshan M.
- Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371.
- PMID: 34573353
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.
- Park B, Kim D, Kim J, Lee BY, Yoon J, Kim SW.
- Cancer Res Treat. 2021 Aug 9. doi: 10.4143/crt.2021.449. Epub ahead of print.
- PMID: 34384016
- PubMed abstract
- Source abstract
-
- Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.
- Wei G, Kumar A, Lee MC, Wang X.
- Clin Breast Cancer. 2021 Aug;21(4):e427-e433. doi: 10.1016/j.clbc.2021.01.008. Epub 2021 Jan 19.
- PMID: 33712364
- PubMed abstract
- Source abstract
-
- Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women.
- Evans DG, Howell SJ, Gandhi A, van Veen EM, Woodward ER, Harvey J, Barr L, Wallace A, Lalloo F, Wilson M, Hurley E, Lim Y, Maxwell AJ, Harkness EF, Howell A.
- Breast Cancer Res Treat. 2021 Jul 26. doi: 10.1007/s10549-021-06333-1. Epub ahead of print.
- PMID: 34312777
- PubMed abstract
-
- Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives.
- Abdel-Razeq H, Tamimi F, Abujamous L, Edaily S, Abunasser M, Bater R, Salama O.
- Cancer Manag Res. 2021 Jun 9;13:4597-4604. doi: 10.2147/CMAR.S316470.
- PMID: 34135636
- PubMed abstract
-
- CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.
- Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, Fountzilas G, Romanidou O, Konstantopoulou I, Fostira F.
- Cancers (Basel). 2021 Apr 27;13(9):2106. doi: 10.3390/cancers13092106.
- PMID: 33925588
- PubMed abstract
- Source abstract
-
- Management of patients with BRCA mutation from the point of view of a breast surgeon.
- Riis ML.
- Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
- PMID: 33996049
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada.
- Narod SA, Gojska N, Sun P, Tryon A, Kotsopoulos J, Metcalfe K, Akbari MR.
- Cancers (Basel). 2021 Apr 15;13(8):1894. doi: 10.3390/cancers13081894.
- PMID: 33920818
- PubMed abstract
- Source abstract
-
- Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.
- Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA.
- Clin Genet. 2021 Apr 12. doi: 10.1111/cge.13966. Epub ahead of print.
- PMID: 33843052
- PubMed abstract
- Free Full Text
-
- Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.
- Meiser B, Kaur R, Morrow A, Peate M, Wong WKT, McPike E, Cops E, Nichols C, Austin R, Fine M, Thrupp L, Ward R, Macrae F, Hiller JE, Trainer AH, Mitchell G; ICCon Audit Study Collaborative Group.
- Hered Cancer Clin Pract. 2021 Apr 9;19(1):24. doi: 10.1186/s13053-021-00180-3.
- PMID: 33836815
- PubMed abstract
-
- Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
- Ložar T, Žgajnar J, Perhavec A, Blatnik A, Novakovic S, Krajc M.
- Eur J Surg Oncol. 2021 Mar 26:S0748-7983(21)00393-0. doi: 10.1016/j.ejso.2021.03.248. Epub ahead of print.
- PMID: 33812767
- PubMed abstract
-
- Screening and Preventative Strategies for Patients at High Risk for Breast Cancer.
- Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K.
- JCO Oncol Pract. 2021 Jan 11:OP2000262. doi: 10.1200/OP.20.00262. Epub ahead of print.
- PMID: 33428469
- PubMed abstract
- Source abstract
-
- Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.
- Cardoso F, MacNeill F, Penault-Llorca F, Eniu A, Sardanelli F, Nordström EB, Poortmans P.
- Breast. 2021 Jan 2;55:128-135. doi: 10.1016/j.breast.2020.12.010. Epub ahead of print.
- PMID: 33461060
- PubMed abstract
-
- Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).
- Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French DP, Evans DG.
- Cancers (Basel). 2020 Dec 9;12(12):3697. doi: 10.3390/cancers12123697.
- PMID: 33317064
- PubMed abstract
- Source abstract
-
- Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation.
- Jung SM, Ryu JM, Park HS, Park JS, Kang E, Lee S, Lee HB, Youn HJ, Yoo TK, Kim J, Lee JE, Han SA, Kim D, Kim SW; Korean Hereditary Breast Cancer Study Group.
- J Breast Cancer. 2020 Dec 3;23(6):647-655. doi: 10.4048/jbc.2020.23.e61.
- PMID: 33408890
- PubMed abstract
- Source abstract
-
- Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program.
- Warner E, Zhu S, Plewes DB, Hill K, Ramsay EA, Causer PA, Seely J, Jong RA, Lenkov P, Elser C, Crystal P, Yaffe MJ, Giannakeas V, Sun P, Narod SA.
- Cancers (Basel). 2020 Nov 23;12(11):3479. doi: 10.3390/cancers12113479.
- PMID: 33238387
- PubMed abstract
- Source abstract
-
- Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants.
- Leitsalu L, Palover M, Sikka TT, Reigo A, Kals M, Pärn K, Nikopensius T, Esko T, Metspalu A, Padrik P, Tõnisson N.
- Eur J Hum Genet. 2020 Nov 23. doi: 10.1038/s41431-020-00760-2. Epub ahead of print.
- PMID: 33230308
- PubMed abstract
- Source abstract
-
- Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness.
- Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Mil Med. 2020 Nov 18:usaa485. doi: 10.1093/milmed/usaa485. Epub ahead of print.
- PMID: 33206196
- PubMed abstract
-
- Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series.
- D'Abbondanza JA, George R, Kives S, Musgrave MA.
- Plast Surg (Oakv). 2020 Nov;28(4):243-248. doi: 10.1177/2292550320928551. Epub 2020 Jun 4.
- PMID: 33215039
- PubMed abstract
- Source abstract
-
- Knowing about an inherited BRCA mutation improves outcomes for women with breast cancer.
- [No author given]
- FORCE. XRAY. 2020 Oct 26.
- Research news
- Free Full Text
Original research:
Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.
- PMID: 32644100
- PubMed abstract
- Free Full Text
-
- Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.
- Galmor L, Bernstein-Molho R, Sklair-Levy M, Madoursky-Feldman D, Zippel D, Laitman Y, Friedman E.
- Breast Cancer Res Treat. 2020 Sep 30. doi: 10.1007/s10549-020-05949-z. Epub ahead of print.
- PMID: 33000375
- PubMed abstract
- Source abstract
-
- Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.
- Bergstrom C, Pence C, Berg J, Partain N, Sadeghi N, Mauer C, Pirzadeh-Miller S, Gao A, Li H, Unni N, Syed S.
- Ann Surg Oncol. 2020 Sep 29. doi: 10.1245/s10434-020-09158-2. Epub ahead of print.
- PMID: 32996020
- PubMed abstract
- Source abstract
-
- Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation.
- Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Narod SA, Evans DG, Liede A.
- Hered Cancer Clin Pract. 2020 Sep 29;18:20. doi: 10.1186/s13053-020-00152-z.
- PMID: 33014209
- PubMed abstract
-
- Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.
- Hadar T, Mor P, Amit G, Lieberman S, Gekhtman D, Rabinovitch R, Levy-Lahad E.
- JAMA Oncol. 2020 Sep 1;6(9):1460-1463. doi: 10.1001/jamaoncol.2020.2059.
- PMID: 32644100
- PubMed abstract
- Source abstract
Research news: Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis. (GenomeWeb)
Research news: 'Knowledge Is Power': Knowing BRCA1/2 Status Tied to Survival. (Medscape)
Research news: Knowing about an inherited BRCA mutation improves outcomes for women with breast cancer. (FORCE. XRAY.)
-
- Management of early breast cancer during the COVID-19 pandemic in Brazil.
- Cavalcante FP, Novita GG, Millen EC, Zerwes FP, de Oliveira VM, Sousa ALL, Freitas Junior R.
- Breast Cancer Res Treat. 2020 Aug 16. doi: 10.1007/s10549-020-05877-y. Epub ahead of print.
- PMID: 32803637
- PubMed abstract
-
- Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
- Cragun D, Weidner A, Tezak A, Clouse K, Pal T.
- Breast Cancer Res Treat. 2020 Jul;182(2):421-428. doi: 10.1007/s10549-020-05699-y. Epub 2020 May 22.
- PMID: 32445176
- PubMed abstract
- Source abstract
-
- Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program.
- Hao J, Hassen D, Manickam K, Murray MF, Hartzel DN, Hu Y, Liu K, Rahm AK, Williams MS, Lazzeri A, Buchanan A, Sturm A, Snyder SR.
- J Pers Med. 2020 Feb 3;10(1). pii: E7. doi: 10.3390/jpm10010007.
- PMID: 32028596
- PubMed abstract
- Source abstract
-
- Prophylactic nipple-sparing mastectomy in young previvors: Examining decision-making, reconstructive outcomes, and patient satisfaction in BRCA+ patients under 30.
- Salibian AA, Bekisz JM, Frey JD, Miller B, Choi M, Karp NS.
- Breast J. 2019 Nov 17. doi: 10.1111/tbj.13692. [Epub ahead of print]
- PMID: 31736224
- PubMed abstract
- Source abstract
-
- Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
- Conley CC, Kasting ML, Augusto BM, Garcia JD, Cragun D, Gonzalez BD, Kim J, Ashing KT, Knott CL, Hughes-Halbert C, Pal T, Vadaparampil ST.
- Ann Surg Oncol. 2019 Nov 1. doi: 10.1245/s10434-019-07982-9. [Epub ahead of print]
- PMID: 31677107
- PubMed abstract
- Source abstract
-
- Hereditary breast cancer: screening and risk reducing surgery.
- Renzulli M, Zanotti S, Clemente A, Mineo G, Tovoli F, Reginelli A, Barile A, Cappabianca S, Taffurelli M, Golfieri R.
- Gland Surg. 2019 Sep;8(Suppl 3):S142-S149. doi: 10.21037/gs.2019.04.04.
- PMID: 31559181
- PubMed abstract
- Source abstract
-
- Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
- Nagura N, Hayashi N, Takei J, Yoshida A, Ochi T, Iwahira Y, Yamauchi H.
- Breast Cancer. 2019 Jul 10. doi: 10.1007/s12282-019-00995-y. [Epub ahead of print]
- PMID: 31292927
- PubMed abstract
- Source abstract
-
- Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: are there factors associated with the choice?
- Manoukian S, Alfieri S, Bianchi E, Peissel B, Azzollini J, Borreani C.
- Psychooncology. 2019 Jul 1. doi: 10.1002/pon.5166. [Epub ahead of print]
- PMID: 31264307
- PubMed abstract
- Source abstract
-
- Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
- Salyer C, Kobelka C, Barrie A, Weintraub MR, Powell CB.
- Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31261-2. doi: 10.1016/j.ygyno.2019.05.017. [Epub ahead of print]
- PMID: 31160070
- PubMed abstract
- Source abstract
-
- International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
- Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- Br J Cancer. 2019 Apr 11. doi: 10.1038/s41416-019-0446-1. [Epub ahead of print]
- PMID: 30971774
- PubMed abstract
- Source abstract
Editorial:
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
- PMID: 31171836
- PubMed abstract
- Free Full Text
-
- Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.
- Grobmyer SR, Pederson HJ, Valente SA, Al-Hilli Z, Radford D, Djohan R, Yetman R, Eng C, Crowe JP.
- BJS Open. 2018 Nov 26;3(2):169-173. doi: 10.1002/bjs5.50117. eCollection 2019 Apr.
- PMID: 30957063
- PubMed abstract
- Source abstract
-
- A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
- Donenberg T, George S, Ali J, Bravo G, Hernandez K, Sookar N, Ashing KT, Narod SA, Akbari MR, Hurley J.
- Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4.
- PMID: 30515680
- PubMed abstract
- Source abstract
-
- Current knowledge of risk reducing mastectomy: Indications, techniques, results, benefits, harms.
- Baildam AD.
- Breast. 2019 Mar 29;46:48-51. doi: 10.1016/j.breast.2019.03.011. [Epub ahead of print]
- PMID: 31082761
- PubMed abstract
- Source abstract
-
- Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE).
- Henry DA, Lee MC, Almanza D, Ahmed KA, Sun W, Boulware DC, Laronga C.
- Breast Cancer Res Treat. 2019 Feb;174(1):39-45. doi: 10.1007/s10549-018-5057-7. Epub 2018 Nov 24.
- PMID: 30474778
- PubMed abstract
- Source abstract
-
- Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
- Hanley GE, McAlpine JN, Cheifetz R, Schrader KA, McCullum M, Huntsman D.
- Curr Oncol. 2019 Feb;26(1):e17-e23. doi: 10.3747/co.26.4068. Epub 2019 Feb 1.
- PMID: 30853805
- PubMed abstract
- Source abstract
-
- Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database.
- Hendrix RJ, Lee C, Friedrich AK, Rouanet E, Larkin AC, LaFemina J.
- Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(19)30050-3. doi: 10.1016/j.clbc.2019.01.008. [Epub ahead of print]
- PMID: 30876714
- PubMed abstract
- Source abstract
-
- High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
- Nilsson MP, Nilsson ED, Borg Å, Brandberg Y, Silfverberg B, Loman N.
- Breast Cancer Res Treat. 2019 Jan;173(2):313-318. doi: 10.1007/s10549-018-5000-y. Epub 2018 Oct 11.
- PMID: 30311024
- PubMed abstract
-
- Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- Narod SA.
- JAMA Oncol. 2018 Dec 1;4(12):1787-1788. doi: 10.1001/jamaoncol.2018.4931.
- PMID: 30383137
- PubMed abstract
- Source abstract
Original Research:
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- PMID: 29801090
- PubMed abstract
- Source abstract
Letter, reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer—Reply
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.
- Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J, Eisen A, Meschino WS, Baxter NN.
- BMJ Open. 2018 Sep 4;8(9):e025317. doi: 10.1136/bmjopen-2018-025317.
- PMID: 30181190
- PubMed abstract
-
- Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.
- Liede A, Cai M, Crouter TF, Niepel D, Callaghan F, Evans DG.
- Breast Cancer Res Treat. 2018 Sep;171(2):435-442. doi: 10.1007/s10549-018-4824-9. Epub 2018 May 28.
- PMID: 29808287
- PubMed abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ.
- JAMA Oncol. 2018 Aug 1;4(8):1066-1072. doi: 10.1001/jamaoncol.2018.0644.
- PMID: 29801090
- PubMed abstract
- Source abstract
Press: Multigene Sequencing Rapidly Replacing BRCA Tests. (Medscape Oncology)
Letter, Comment:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- PMID: 30383137
- PubMed abstract
- Source abstract
Letter, Reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply.
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
- Long J, Evans TG, Bailey D, Lewis MH, Gower-Thomas K, Murray A.
- Breast J. 2018 Jul;24(4):580-585. doi: 10.1111/tbj.12978. Epub 2017 Dec 29.
- PMID: 29286205
- PubMed abstract
- Source abstract
-
- Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.
- Kearton S, Wills K, Bunting M, Blomfield P, James PA, Burke J.
- Fam Cancer. 2018 Jul;17(3):333-344. doi: 10.1007/s10689-017-0047-1.
- PMID: 29039136
- PubMed abstract
- Source abstract
-
- Immediate Breast Reconstruction: Comparative Outcome Study of One-Stage Direct-to-Implant and Two-Stage/Tissue Expander Techniques.
- Meshulam-Derazon S, Shay T, Lewis S, Adler N.
- Isr Med Assoc J. 2018 Jun;20(6):340-344.
- PMID: 29911752
- PubMed abstract
-
- Juliet's story: No reconstruction is a post-mastectomy option.
- [No author given]
- FORCE. XRAYS. 2018 May 24.
- Review, Commentary
- Free Full Text
Blog post: I felt empowered by choosing not to have a reconstruction. (Breast Cancer Care)
-
- Risk management decisions in women with BRCA1 and BRCA2 mutations.
- Morgan R, Brown A, Hamman KJ, Sampson J, Naik A, Massimino K.
- Am J Surg. 2018 May;215(5):899-903. doi: 10.1016/j.amjsurg.2018.02.010. Epub 2018 Feb 13.
- PMID: 29499861
- PubMed abstract
- Source abstract
-
- Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
- Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, Sakurai A, Sekine M, Yotsumoto J, Nomura H, Akama Y, Inuzuka M, Nomizu T, Enomoto T, Nakamura S.
- J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
- PMID: 29176636
- PubMed abstract
-
- Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation.
- Narod SA, Butler R, Bobrowski D, Akbari MR, Curling D, Lunn J, Ho C, Panahi S, Llacuachaqui M, Donenberg T, Hurley J.
- Mol Genet Genomic Med. 2018 Mar;6(2):301-304. doi: 10.1002/mgg3.363. Epub 2017 Dec 20.
- PMID: 29266833
- PubMed abstract
- Source abstract
-
- The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study.
- Câmara S, Pereira D, André S, Mira B, Vaz F, Oom R, Marques JC, Leal de Faria J, Rodrigues Dos Santos C.
- Int J Breast Cancer. 2018 Jan 1;2018:1426369. doi: 10.1155/2018/1426369. eCollection 2018.
- PMID: 29507815
- PubMed abstract
- Source abstract
-
- Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
- Gilbert E, Zabor EC, Stempel M, Mangino D, Heerdt A, Pilewskie M.
- Ann Surg Oncol. 2017 Oct;24(10):3048-3054. doi: 10.1245/s10434-017-5976-2. Epub 2017 Aug 1.
- PMID: 28766223
- PubMed abstract
- Source abstract
-
- Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
- Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, Boughey JC.
- Ann Surg Oncol. 2017 Oct;24(10):3067-3072. doi: 10.1245/s10434-017-5959-3. Epub 2017 Aug 1.
- PMID: 28766224
- PubMed abstract
- Source abstract
-
- BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.
- Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.
- MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.
- PMID: 28880857
- PubMed abstract
-
- Do All BRCA 1 and 2 Carriers with a Known and Unknown Breast Cancer Choose Bilateral Mastectomies?
- Gaffley M, Villa A, Vu T, Steelman S, Howard-McNatt M.
- Am Surg. 2018 Sep 1;84(9):1544-1545.
- PMID: 30268191
- PubMed abstract
- Source abstract
-
- Quality of Patient Decisions About Breast Reconstruction After Mastectomy.
- Lee CN, Deal AM, Huh R, Ubel PA, Liu YJ, Blizard L, Hunt C, Pignone MP.
- JAMA Surg. 2017 Aug 1;152(8):741-748. doi: 10.1001/jamasurg.2017.0977.
- PMID: 28467530
- PubMed abstract
-
- Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.
- Schott S, Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Dikow N, Evers C, Sohn C, Heil J.
- Arch Gynecol Obstet. 2017 Jun;295(6):1451-1458. doi: 10.1007/s00404-017-4376-y. Epub 2017 Apr 24.
- PMID: 28439664
- PubMed abstract
- Source abstract
-
- Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer.
- Lee J, Kim S, Kang E, Park S, Kim Z, Lee MH; Korean Breast Cancer Society.
- J Breast Cancer. 2017 Jun;20(2):203-207. doi: 10.4048/jbc.2017.20.2.203. Epub 2017 Jun 26.
- PMID: 28690658
- PubMed abstract
- Source abstract
-
- Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients.
- Head L, Nessim C, Usher Boyd K.
- Can J Surg. 2017 Feb;60(1):37-44.
- PMID: 28234588
- PubMed abstract
- Source abstract
-
- Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.
- Ma IT, Gray RJ, Wasif N, Butler KA, Cornella JL, Magrina JF, Magtibay PM, Casey WJ, Mahabir R, Rebecca AM, Hunt KS, Pockaj BA.
- Ann Surg Oncol. 2017 Jan;24(1):77-83. doi: 10.1245/s10434-016-5479-6. Epub 2016 Aug 31.
- PMID: 27581610
- PubMed abstract
- Source abstract
-
- Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial.
- Desai S, Jena AB.
- BMJ. 2016 Dec 14;355:i6357. doi: 10.1136/bmj.i6357.
- PMID: 27974323
- PubMed abstract
Research News:
Angelina Jolie's mastectomy triggered sharp rise in gene testing.
- PMID: 27979800
- PubMed abstract
- Source abstract
Research News: Angelina Jolie spoke out on BRCA testing: Did genetic testing increase? (FORCE)
Blog post: "Angelina Jolie Effect”: What Should I Know About Hereditary Cancer and Testing? (NSGC Blog)
Research News: Were women foolish to follow Angelina Jolie into BRCA cancer gene testing? (STAT)
Research News: Jolie Effect: BRCA Tests Up but No Change in Mastectomy. (Medscape)
-
- Risk-reducing mastectomy.
- Chiesa F, Sacchini V.
- Minerva Ginecol. 2016 Oct;68(5):544-7. Epub 2016 Jan 19.
- PMID: 26785281
- PubMed abstract
- Source abstract
-
- Has the Angelina Jolie effect led to an increase in risk reducing mastectomy and breast reconstruction in Wales: A retrospective, single centre cohort study.
- Malcolm CM, Javed MU, Nguyen D.
- J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):288-9. doi: 10.1016/j.bjps.2015.10.018. Epub 2015 Oct 26.
- PMID: 26546111
- PubMed abstract
- Source abstract
-
- Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.
- Flippo-Morton T, Walsh K, Chambers K, Amacker-North L, White B, Sarantou T, Boselli DM, White RL Jr.
- Breast J. 2016 Jan-Feb;22(1):35-44. doi: 10.1111/tbj.12521. Epub 2015 Dec 23.
- PMID: 26695813
- PubMed abstract
- Source abstract
-
- Legislation regulating availability of breast cancer treatment with particular focus on prophylactic mastectomy.
- Rolska P, Łapa J.
- Folia Med Cracov. 2016;56(2):73-94.
- PMID: 28013324
- PubMed abstract
- ToC
-
- Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women.
- Evans DG, Wisely J, Clancy T, Lalloo F, Wilson M, Johnson R, Duncan J, Barr L, Gandhi A, Howell A.
- Breast Cancer Res. 2015 Nov 25;17:143. doi: 10.1186/s13058-015-0650-8.
- PMID: 26603733
- PubMed abstract
- Commentary, Letter
- Free PMC article
- Free Full Text
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
- PMID: 25510853
- PubMed abstract
Blog post: The Angelina Jolie effect (BioMed Central)
-
- Risk assessment: Physicians discuss motivations for rising rates of prophylactic mastectomies.
- Printz C.
- Cancer. 2015 Jun 1;121(11):1721-2. doi: 10.1002/cncr.28996.
- PMID: 25994526
- PubMed abstract
- Source abstract
- News
- Free Full Text
-
- Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
- Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Tung N, Weitzel JN, Couch FJ, Hulick PJ, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Blum JL, Domchek SM, Chen J, Rebbeck TR.
- Breast Cancer Res Treat. 2014 Nov;148(2):397-406. doi: 10.1007/s10549-014-3134-0. Epub 2014 Oct 14.
- PMID: 25311111
- PubMed abstract
- Source abstract
-
- The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
- Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, Donaldson A, Brady AF, Cuthbert A, Harrison R, Thomas S, Howell A; The FH02 Study Group; RGC teams, Miedzybrodzka Z, Murray A; The FH02 Study Group; RGC Teams.
- Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
- PMID: 25510853
- PubMed abstract
Comment, Letter:
Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women.
- PMID: 26603733
- PubMed abstract
- Free Full Text
-
- Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
- Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL.
- JAMA. 2014 Sep 3;312(9):902-14. doi: 10.1001/jama.2014.10707.
- PMID: 25182099
- PubMed abstract
Editorial, Comment:
Contralateral prophylactic mastectomy: is it a reasonable option?
- PMID: 25182096
- PubMed abstract
- Source abstract
-
- Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers.
- Khansa I, Wang D, Coriddi M, Tiwari P.
- Microsurgery. 2014 May;34(4):271-6. doi: 10.1002/micr.22195. Epub 2013 Oct 7.
- PMID: 24123194
- PubMed abstract
- Source abstract
-
- Changes in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.
- Matloff ET, Bonadies DC, Moyer A, Brierley KL.
- J Genet Couns. 2014 Apr;23(2):164-71. doi: 10.1007/s10897-013-9625-z. Epub 2013 Jul 13.
- PMID: 23852268
- PubMed abstract
- Source abstract
Press: What’s Ahead for BRCA Genetic Testing and Counseling? (OncLive)
-
- Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers.
- Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P.
- Breast. 2014 Feb;23(1):38-43. doi: 10.1016/j.breast.2013.10.002. Epub 2013 Nov 5.
- PMID: 24210736
- PubMed abstract
- Source abstract
-
- Risk management options elected by women after testing positive for a BRCA mutation.
- Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB.
- Gynecol Oncol. 2014 Feb;132(2):428-33. doi: 10.1016/j.ygyno.2013.12.014. Epub 2013 Dec 16.
- PMID: 24355485
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timing.
- van Driel CM, Eltahir Y, de Vries J, Jaspers JP, Oosterwijk JC, Mourits MJ, de Bock GH.
- Maturitas. 2014 Feb;77(2):180-4. doi: 10.1016/j.maturitas.2013.10.017. Epub 2013 Nov 1.
- PMID: 24268650
- PubMed abstract
- Source abstract
-
- International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers.
- Semple J, Metcalfe KA, Lynch HT, Kim-Sing C, Senter L, Pal T, Ainsworth P, Lubinski J, Tung N, Eng C, Gilchrist D, Blum J, Neuhausen SL, Singer CF, Ghadirian P, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.
- Ann Surg Oncol. 2013 Nov;20(12):3817-22. doi: 10.1245/s10434-013-3040-4. Epub 2013 Jun 6.
- PMID: 23740344
- PubMed abstract
- Source abstract
-
- Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
- Culver J, Brinkerhoff C, Clague J, Yang K, Singh K, Sand S, Weitzel J.
- Clin Genet. 2013 Nov;84(5):464-472. doi: 10.1111/cge.12097. Epub 2013 Feb 20.
- PMID: 23323793
- PubMed abstract
- Source abstract
-
- Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics.
- Neuburger J, Macneill F, Jeevan R, van der Meulen JH, Cromwell DA.
- BMJ Open. 2013 Aug 1;3(8). pii: e003179. doi: 10.1136/bmjopen-2013-003179.
- PMID: 23906951
- PubMed abstract
- Source abstract
-
- Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
- Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O.
- Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi: 10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17.
- PMID: 23333547
- PubMed abstract
- Source abstract
-
- Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
- This P, de la Rochefordière A, Savignoni A, Falcou MC, Tardivon A, Thibault F, Alran S, Fourchotte V, Fitoussi A, Couturaud B, Dolbeault S, Salmon RJ, Sigal-Zafrani B, Asselain B, Stoppa-Lyonnet D.
- Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1.
- PMID: 22711610
- PubMed abstract
- Source abstract
-
- Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
- Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A.
- Ann Surg Oncol. 2012 Aug;19(8):2600-6. doi: 10.1245/s10434-012-2299-1. Epub 2012 Mar 7.
- PMID: 22396004
- PubMed abstract
- Source abstract
-
- How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
- Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M, Duffy J, Kelly PJ, Gleeson M, Barlow-Stewart K, Rahman B, Friedlander M, Tucker K; TFGT Collaborative Group.
- BMC Cancer. 2012 Jul 28;12:320. doi: 10.1186/1471-2407-12-320.
- PMID: 22838957
- PubMed abstract
-
- Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
- Bayraktar S, Elsayegh N, Gutierrez Barrera AM, Lin H, Kuerer H, Tasbas T, Muse KI, Ready K, Litton J, Meric-Bernstam F, Hortobagyi GN, Albarracin CT, Arun B.
- Cancer. 2012 Mar 15;118(6):1515-22. doi: 10.1002/cncr.26428. Epub 2011 Aug 25.
- PMID: 22009639
- PubMed abstract
- Source abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: Does anyone have a good reference for the occurence of DCIS in hereditary cancer syndromes?
-
- Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
- Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L.
- Cancer. 2012 Jan 15;118(2):510-7. doi: 10.1002/cncr.26294. Epub 2011 Jun 29.
- PMID: 21717445
- PubMed abstract
- Source abstract